Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DuPont Guerry

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanomaXiaowei Xu, Lianjun Chen, DuPont Guerry, et al.
Annals of Surgical Oncology|July 11, 2013
Local immune response predicts survival in patients with thick (t4) melanomasJessica A Cintolo, Phyllis Gimotty, Anne Blair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Recombinant CD63/ME491/neuroglandular/NKI/C-3 antigen inhibits growth of established tumors in transgenic miceJian Li, Weiping Li, Shaohong Liang, et al.
Annals of Surgical Oncology|March 9, 2006
Predictors of regional nodal disease in patients with thin melanomasGiorgos C Karakousis, Phyllis A Gimotty, Jeffrey D Botbyl, et al.
Cancer|November 6, 2004
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control studyJoni L Rutter, Christina M Bromley, Alisa M Goldstein, et al.
Cancer Research|March 17, 2006
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patientsRajasekharan Somasundaram, Rolf Swoboda, Laura Caputo, et al.
Cancer Research|April 19, 2007
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage displayRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2003
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 gangliosideSaroj Basak, Brigitte Birebent, Enkhtsetseg Purev, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2011
Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanomaXiaowei Xu, Lianjun Chen, DuPont Guerry, et al.
Annals of Surgical Oncology|July 11, 2013
Local immune response predicts survival in patients with thick (t4) melanomasJessica A Cintolo, Phyllis Gimotty, Anne Blair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Recombinant CD63/ME491/neuroglandular/NKI/C-3 antigen inhibits growth of established tumors in transgenic miceJian Li, Weiping Li, Shaohong Liang, et al.
Annals of Surgical Oncology|March 9, 2006
Predictors of regional nodal disease in patients with thin melanomasGiorgos C Karakousis, Phyllis A Gimotty, Jeffrey D Botbyl, et al.
Cancer|November 6, 2004
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control studyJoni L Rutter, Christina M Bromley, Alisa M Goldstein, et al.
Cancer Research|March 17, 2006
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patientsRajasekharan Somasundaram, Rolf Swoboda, Laura Caputo, et al.
Cancer Research|April 19, 2007
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage displayRolf K Swoboda, Rajasekharan Somasundaram, Laura Caputo, et al.
Cancer Immunology, Immunotherapy : CII|March 22, 2003
Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 gangliosideSaroj Basak, Brigitte Birebent, Enkhtsetseg Purev, et al.
Pageof 5